Polyrizon Ltd. PLRZ

Annual Quarterly

No annual revenue total was found in Polyrizon Ltd.'s SEC filings.

Polyrizon Ltd. (PLRZ) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. Free cash flow was -$4.5 million.

Revenue
—
Net income
$-3.33M
-115.9% vs prior year
Operating cash flow
$-4.53M
-294.8% vs prior year
Free cash flow
$-4.54M
EPS
$4.90
-99.4% vs prior year
Dividend per share
None
Shares outstanding
1.61M
-61.7% vs prior year
Net cash
—
Operating margin
—

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
PLRZ (Nasdaq)
Fiscal year ends
December 31
Incorporated in
Israel
Headquarters
Ra'Anana
SEC filer status
Non-accelerated filer, Emerging growth company
SEC CIK
1893645

Other Surgical & Medical Instruments & Apparatus companies

Key figures

Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.

Line
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
Operating income
-$6.2M
-$1.3M
Net income
-$3.3M
-$1.5M
Diluted EPS
$4.90
$805.20
Operating cash flow
-$4.5M
-$1.1M
Free cash flow
-$4.5M
—
Total assets
$21.4M
$5.5M
Stockholders' equity
$21.0M
$5.3M
Cash and investments
$1.3M
$2.6M

Recent SEC filings

Recent SEC filings
Form Description Filed Period
6-K Current report (foreign issuer) Oct 27, 2026 Oct 27, 2026
6-K Current report (foreign issuer) Oct 5, 2026 Oct 5, 2026
6-K Current report (foreign issuer) Sep 28, 2026 Jun 30, 2026
6-K Current report (foreign issuer) Sep 4, 2026 Sep 4, 2026
6-K Current report (foreign issuer) Sep 4, 2026 Sep 4, 2026
6-K Current report (foreign issuer) Aug 20, 2026 Aug 20, 2026

Source: SEC EDGAR filings. This is company-reported data, not investment advice.